4-Cyano-4-[(dodecylsulfanylthiocarbonyl)sulfanyl]pentanol, 98%, 5g

Thalidomide-O-amido-PEG2-C2-NH2 (TFA), 1g

2-Amino-N-isopropylbenzamide, 95.0%, 1g

(R)-methyl 2-(6-hydroxy-2,3-dihydrobenzofuran-3-yl)acetate, 95%, 100mg

12-Oxo-12H-benzo[g]pyrido[2,1-b]quinazoline-4-carboxylic acid, 97%, 500mg

2-(5-Chloro-2-fluorophenyl)-N-(pyridin-4-yl)pteridin-4-amine, 98%, 1g

Diethyl 2,5-Dibromoadipate>98.0%(GC)5g

4,8-dichloro[1]benzofuro[3,2-d]pyrimidine, 97%, 25g

N-Benzoyl-4-hydroxypiperidine, 97%, 100mg

3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazolo[1,5-a]pyridine, 95.0%, 50mg

S-(Benzo[d]thiazol-2-yl)-N,N-dicyclohexylthiohydroxylamine, 95.0%, 1g

2-((2-Acetamido-6-oxo-1H-purin-9(6H)-yl)methoxy)ethyl acetate, 97.0%, 5g

2-(4-CHLORO-3-NITRO-BENZENESULFONYLAMINO)-BENZOIC ACID, 95%, 1g